Date/Time
Date(s) - 01/08/2023 - 11/08/2023
12:00 am
Categories
This technology transfer course is structured to provide efficient turn-key knowledge regarding the process of technical & bureaucratic workflow description, examination and finalization of technology transfer process by inventors Erdal Can Alkoclar and Metehan Yesil accompanied by the finance support of Spektral Investment Bank to developing countries which are in requirement of independent pharmaceutical & bioceutical technologies.
The patent portfolio herein disclosed consists of:
BCL-2 EXPRESSION INHIBITORS, CYCLIN B1 & D2 INHIBITORS, HIF-10 SUPPRESSIVE AGENTS, TNF-A & NF-KAPPA B COX-2 INTERLEUKIN-6 SUPPRESSIVE AND IMMUNOMODULATIVE AGENTS FOR AUTOIMMUNE DISEASES, FMO3 SUPPRESSIVE ANALGESIC AGENTS, THYROGENIC & THYROMODULATORY AGENTS, RNA POLYMERASE & DNA POLYMERASE & VIRAL DNA GYRASE SUPPRESSIVE ANTIVIRAL AGENTS, TOPOISOMERASE I & II, RIBONUCLEOTIDE REDUCTASE SUPPRESSIVE ANTIBACTERIAL AGENTS, GLUT4 TRANSLOCATIVE ANTIDIABETIC AGENTS.
Co-invented by Erdal Can Alkoclar and Metehan Yesil, above – mentioned patents have been licensed and / or currently being negotiated to be licensed to pharmaceutical companies in several developing countries including Bosnia, Senegal, Luxembourg and Libya.
Course provides real-world tested know – how regarding the initiation , facilitation and finalization of technology transfer processes including the political, scientific and bureaucratic aspects of the process.